This combination effectively enhanced TRAIL-induced apoptosis in bladder cancer cells without being cytotoxic to normal bladder epithelium cells, suggesting its potential clinical value for bladder cancer treatment [62]. This evidence concerns the gene TNFSF10 and urinary bladder carcinoma.